17-7592810-G-C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_004860.4(FXR2):āc.1613C>Gā(p.Pro538Arg) variant causes a missense change. The variant allele was found at a frequency of 0.000162 in 1,613,108 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P538L) has been classified as Uncertain significance.
Frequency
Consequence
NM_004860.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FXR2 | NM_004860.4 | c.1613C>G | p.Pro538Arg | missense_variant | 14/17 | ENST00000250113.12 | |
FXR2 | XM_047437106.1 | c.1613C>G | p.Pro538Arg | missense_variant | 14/17 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FXR2 | ENST00000250113.12 | c.1613C>G | p.Pro538Arg | missense_variant | 14/17 | 1 | NM_004860.4 | P1 | |
FXR2 | ENST00000704984.1 | c.1832C>G | p.Pro611Arg | missense_variant | 14/17 | ||||
MPDU1 | ENST00000423172.6 | downstream_gene_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152116Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000570 AC: 14AN: 245674Hom.: 0 AF XY: 0.0000523 AC XY: 7AN XY: 133824
GnomAD4 exome AF: 0.000175 AC: 255AN: 1460992Hom.: 0 Cov.: 32 AF XY: 0.000191 AC XY: 139AN XY: 726796
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152116Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74308
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 21, 2023 | The c.1613C>G (p.P538R) alteration is located in exon 14 (coding exon 14) of the FXR2 gene. This alteration results from a C to G substitution at nucleotide position 1613, causing the proline (P) at amino acid position 538 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at